LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$75.58−0.52 (-0.68%)
Close on Nov 18, 2026Market cap $1.73BP/E 26.5Yield 1.06%
LeMaitre Vascular revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
LeMaitre Vascular's revenue for the twelve months ending Jun 30, 2026 was $262.43M, up 11.8% year over year. For fiscal 2025 it was $249.60M, up 13.5% from the year before. Over ten years it grew 12.3% a year on average. The highest annual figure on record is $249.60M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $249.60M | +13.5% |
| FY2024 | Dec 31, 2024 | $219.86M | +13.6% |
| FY2023 | Dec 31, 2023 | $193.48M | +19.7% |
| FY2022 | Dec 31, 2022 | $161.65M | +4.7% |
| FY2021 | Dec 31, 2021 | $154.42M | +19.4% |
| FY2020 | Dec 31, 2020 | $129.37M | +10.4% |
| FY2019 | Dec 31, 2019 | $117.23M | +11.0% |
| FY2018 | Dec 31, 2018 | $105.57M | +4.7% |
| FY2017 | Dec 31, 2017 | $100.87M | +13.1% |
| FY2016 | Dec 31, 2016 | $89.15M | +13.8% |
| FY2015 | Dec 31, 2015 | $78.35M | +10.2% |
| FY2014 | Dec 31, 2014 | $71.10M | +10.1% |
| FY2013 | Dec 31, 2013 | $64.55M | +13.8% |
| FY2012 | Dec 31, 2012 | $56.74M | -1.6% |
| FY2011 | Dec 31, 2011 | $57.69M | +2.9% |
| FY2010 | Dec 31, 2010 | $56.06M | +10.1% |
| FY2009 | Dec 31, 2009 | $50.91M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $70.38M | +9.6% |
| Q1 FY2026 | Mar 31, 2026 | $66.55M | +11.2% |
| Q4 FY2025 | Dec 31, 2025 | $64.45M | +15.7% |
| Q3 FY2025 | Sep 30, 2025 | $61.05M | +11.4% |
| Q2 FY2025 | Jun 30, 2025 | $64.23M | +15.0% |
| Q1 FY2025 | Mar 31, 2025 | $59.87M | +12.0% |
| Q4 FY2024 | Dec 31, 2024 | $55.72M | +14.0% |
| Q3 FY2024 | Sep 30, 2024 | $54.82M | +15.6% |
| Q2 FY2024 | Jun 30, 2024 | $55.85M | +11.4% |
| Q1 FY2024 | Mar 31, 2024 | $53.48M | +13.6% |
| Q4 FY2023 | Dec 31, 2023 | $48.88M | +19.4% |
| Q3 FY2023 | Sep 30, 2023 | $47.41M | +21.5% |
| Q2 FY2023 | Jun 30, 2023 | $50.12M | +19.0% |
| Q1 FY2023 | Mar 31, 2023 | $47.08M | +19.0% |
| Q4 FY2022 | Dec 31, 2022 | $40.95M | +3.7% |
| Q3 FY2022 | Sep 30, 2022 | $39.03M | +1.7% |
| Q2 FY2022 | Jun 30, 2022 | $42.11M | +3.5% |
| Q1 FY2022 | Mar 31, 2022 | $39.56M | +10.2% |
| Q4 FY2021 | Dec 31, 2021 | $39.50M | +5.2% |
| Q3 FY2021 | Sep 30, 2021 | $38.37M | +5.4% |
| Q2 FY2021 | Jun 30, 2021 | $40.67M | +63.7% |
| Q1 FY2021 | Mar 31, 2021 | $35.88M | +17.5% |
| Q4 FY2020 | Dec 31, 2020 | $37.55M | +24.5% |
| Q3 FY2020 | Sep 30, 2020 | $36.42M | +25.1% |
| Q2 FY2020 | Jun 30, 2020 | $24.85M | -15.7% |
| Q1 FY2020 | Mar 31, 2020 | $30.55M | +7.3% |
| Q4 FY2019 | Dec 31, 2019 | $30.17M | +6.3% |
| Q3 FY2019 | Sep 30, 2019 | $29.10M | +20.4% |
| Q2 FY2019 | Jun 30, 2019 | $29.48M | +9.1% |
| Q1 FY2019 | Mar 31, 2019 | $28.48M | +9.6% |
| Q4 FY2018 | Dec 31, 2018 | $28.39M | +8.5% |
| Q3 FY2018 | Sep 30, 2018 | $24.17M | -2.6% |
| Q2 FY2018 | Jun 30, 2018 | $27.02M | +4.9% |
| Q1 FY2018 | Mar 31, 2018 | $25.99M | +7.7% |
| Q4 FY2017 | Dec 31, 2017 | $26.15M | +12.3% |
| Q3 FY2017 | Sep 30, 2017 | $24.82M | +6.9% |
| Q2 FY2017 | Jun 30, 2017 | $25.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $24.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $23.29M | – |
| Q3 FY2016 | Sep 30, 2016 | $23.22M | – |
See a number that looks wrong?